Ponatinib in chronic myeloid leukaemia: ready for first-line?
- PMID: 26685767
- DOI: 10.1016/S2352-3026(15)00130-1
Ponatinib in chronic myeloid leukaemia: ready for first-line?
Comment on
-
Ponatinib as first-line treatment for patients with chronic myeloid leukaemia in chronic phase: a phase 2 study.Lancet Haematol. 2015 Sep;2(9):e376-83. doi: 10.1016/S2352-3026(15)00127-1. Lancet Haematol. 2015. PMID: 26436130 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
